TP53 and cancer: The two earliest studies (Mulvihill et al. 2001; Hecht et al. 2003) investigated ONYX-015, which is an adenovirus with a deletion of the E1B-55 kDa region which allows it to replicate selectively inside cancer cells with abnormalities in the p53 pathway, including pancreatic ductal adenocarcinoma cells.